Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

China flag China · Delayed Price · Currency is CNY
23.27
+0.11 (0.47%)
Apr 28, 2026, 3:04 PM CST
28.07%
Market Cap 22.49B
Revenue (ttm) 1.17B
Net Income (ttm) 31.83M
Shares Out 966.49M
EPS (ttm) 0.04
PE Ratio 706.51
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 15,192,776
Average Volume 19,509,078
Open 22.97
Previous Close 23.16
Day's Range 22.90 - 23.82
52-Week Range 16.83 - 30.20
Beta 0.45
RSI 60.00
Earnings Date Apr 22, 2026

About SHE:000766

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. The company provides anti-tumor drugs, gynecological medications, medication for rheumatic bone pain, urological medications, heat-clearing and detoxifying drugs, cardiovascular and cerebrovascular drugs, digestive medications, tonifying and restorative medicines, respiratory medication, diabetes medication, ENT medication, and pediatric medications. It also offers... [Read more]

Sector Healthcare
Founded 1990
Employees 1,480
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000766
Full Company Profile

Financial Performance

In 2025, SHE:000766's revenue was 1.17 billion, a decrease of -11.54% compared to the previous year's 1.32 billion. Earnings were 34.29 million, a decrease of -39.25%.

Financial Statements

News

There is no news available yet.